Literature DB >> 22997692

Bacteriological results and leprosy reactions among MB leprosy patients treated with uniform multidrug therapy in China.

Jianping Shen1, Nagaraju Bathyala, Axel Kroeger, Byron Arana, Vijay Pannikar, Hongjiang Mou, Xia Bao, Rongde Yang, P Manickam, Wenzhong Li, Min Zhou, Juan Want.   

Abstract

OBJECTIVES: To investigate the changes of bacteriological index and leprosy reactions among Multi-bacillary (MB) patients treated with uniform multi-drug therapy (UMDT).
METHODS: Newly diagnosed leprosy patients were recruited after taking informed consent in three districts in Guizhou Province and one district in Yunnan Province China during November 2003 to June 2005 and were treated with Uniform Multidrug Therapy. All patients were followed up once a year for 3 years after completion of treatment. All data on bacteriological index (BI) and the frequencies of leprosy reaction were collected and analysed.
RESULTS: A total of 166 patients were recruited for UMDT trial. Among them 114 patients had positive BI smear, and 83 patients had been followed up for 42 months. The mean BI of 83 patients decreased from 2.84 before treatment to 0.33 at the end of 42 months follow-up. At the end of this period, 61 patients (73.5%) had become BI negative. There were 13 (14.6%) patients who had a Type I reaction during 24 months of follow-up. One patient in the study group relapsed 13 months after stopping treatment of the UMDT.
CONCLUSION: There was a significant decrease in the mean BI and 73.5% of patients treated with UMDT became BI negative during 3 years' follow-up. The frequency of Type I reaction seemed a little higher among patients treated with UMDT, but the numbers of patients enrolled were too few to determine statistical significance. Future studies on U-MDT should also study Type I reactions in these patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22997692

Source DB:  PubMed          Journal:  Lepr Rev        ISSN: 0305-7518            Impact factor:   0.537


  5 in total

1.  Rapid quantitative serological test for detection of infection with Mycobacterium leprae, the causative agent of leprosy.

Authors:  Malcolm S Duthie; Marivic F Balagon; Armi Maghanoy; Florenda M Orcullo; Marjorie Cang; Ronaldo Ferreira Dias; Marco Collovati; Steven G Reed
Journal:  J Clin Microbiol       Date:  2013-12-11       Impact factor: 5.948

2.  Global leprosy program: Does it need uniform-multi-drug therapy now?

Authors:  P Narasimha Rao; Sunil Dogra; Sujai Suneetha
Journal:  Indian Dermatol Online J       Date:  2015 Nov-Dec

3.  Can baseline ML Flow test results predict leprosy reactions? An investigation in a cohort of patients enrolled in the uniform multidrug therapy clinical trial for leprosy patients in Brazil.

Authors:  Emerith Mayra Hungria; Regiane Morillas Oliveira; Gerson Oliveira Penna; Lúcio Cartaxo Aderaldo; Maria Araci de Andrade Pontes; Rossilene Cruz; Heitor de Sá Gonçalves; Maria Lúcia Fernandes Penna; Ligia Regina Franco Sansigolo Kerr; Mariane Martins de Araújo Stefani; Samira Bührer-Sékula
Journal:  Infect Dis Poverty       Date:  2016-12-06       Impact factor: 4.520

4.  Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients.

Authors:  Gerson Oliveira Penna; Samira Bührer-Sékula; Lígia Regina Sansigolo Kerr; Mariane Martins de Araújo Stefani; Laura Cunha Rodrigues; Marcelo Grossi de Araújo; Andrea Machado Coelho Ramos; Ana Regina Coelho de Andrade; Maurício Barcelos Costa; Patricia Sammarco Rosa; Heitor de Sá Gonçalves; Rossilene Cruz; Maurício Lima Barreto; Maria Araci de Andrade Pontes; Maria Lúcia Fernandes Penna
Journal:  PLoS Negl Trop Dis       Date:  2017-07-13

5.  International open trial of uniform multidrug therapy regimen for leprosy patients: Findings & implications for national leprosy programmes.

Authors:  Ponnaiah Manickam; Sanjay M Mehendale; Bathyala Nagaraju; Kiran Katoch; Abdul Jamesh; Ramalingam Kutaiyan; Shen Jianping; Shivakumar Mugudalabetta; Vitthal Jadhav; Prabu Rajkumar; Jayasree Padma; Kanagasabai Kaliaperumal; Vijayakumar Pannikar; Padabettu Krishnamurthy; Mohan D Gupte
Journal:  Indian J Med Res       Date:  2016-10       Impact factor: 2.375

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.